{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "regularMarketChangePercent": 0.23844133, "regularMarketPrice": 42.04, "earningsTimestamp": 1683721800, "earningsTimestampStart": 1690288200, "earningsTimestampEnd": 1690806600, "trailingAnnualDividendRate": 0.0, "trailingPE": 11.549451, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": 3.64, "epsForward": 2.71, "epsCurrentYear": 3.24, "priceEpsCurrentYear": 12.975308, "sharesOutstanding": 52366700, "bookValue": 9.743, "fiftyDayAverage": 40.2864, "fiftyDayAverageChange": 1.7536011, "fiftyDayAverageChangePercent": 0.043528363, "twoHundredDayAverage": 41.59605, "twoHundredDayAverageChange": 0.44395065, "twoHundredDayAverageChangePercent": 0.010672904, "marketCap": 2255601664, "forwardPE": 15.512916, "priceToBook": 4.314893, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.8 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1196841600000, "priceHint": 2, "marketState": "POSTPOST", "exchange": "MCE", "shortName": "LABORATORIOS FARMACEUTICOS ROVI", "longName": "Laboratorios Farmaceuticos Rovi, S.A.", "messageBoardId": "finmb_13539385", "exchangeTimezoneName": "Europe/Madrid", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "es_market", "esgPopulated": false, "regularMarketChange": 0.10000229, "regularMarketTime": 1683905709, "regularMarketDayHigh": 42.34, "regularMarketDayRange": "41.7 - 42.34", "regularMarketDayLow": 41.7, "regularMarketVolume": 76426, "regularMarketPreviousClose": 41.94, "bid": 42.02, "ask": 42.04, "bidSize": 0, "askSize": 0, "fullExchangeName": "MCE", "financialCurrency": "EUR", "regularMarketOpen": 42.34, "averageDailyVolume3Month": 153567, "averageDailyVolume10Day": 126195, "fiftyTwoWeekLowChange": 6.84, "fiftyTwoWeekLowChangePercent": 0.19431818, "fiftyTwoWeekRange": "35.2 - 63.9", "fiftyTwoWeekHighChange": -21.86, "fiftyTwoWeekHighChangePercent": -0.342097, "fiftyTwoWeekLow": 35.2, "fiftyTwoWeekHigh": 63.9, "symbol": "ROVI.MC"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Calle Jos\u00e9 Isbert, 2", "address2": "Pozuelo de Alarc\u00f3n", "city": "Madrid", "zip": "28223", "country": "Spain", "phone": "34 91 021 30 00", "website": "https://www.rovi.es", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company distributes other products that are licensed from other laboratories. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa. It provides non-prescription pharmaceutical products; and contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, hard capsules, and sachets. The company was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmace\u00faticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.", "fullTimeEmployees": 1993, "companyOfficers": [{"maxAge": 1, "name": "Mr. Juan  Lopez-Belmonte Encina", "title": "Pres & CEO", "fiscalYear": 2022, "totalPay": {"raw": 1146000, "fmt": "1.15M", "longFmt": "1,146,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ivan  Lopez-Belmonte Encina", "title": "Second Deputy Chairman & Head of Corp. Devel.", "fiscalYear": 2022, "totalPay": {"raw": 462000, "fmt": "462k", "longFmt": "462,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Javier  Lopez-Belmonte Encina", "title": "First Deputy Chairman & CFO", "fiscalYear": 2022, "totalPay": {"raw": 466000, "fmt": "466k", "longFmt": "466,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Marta Campos Mart\u00ednez", "title": "Head of Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Mercedes Ben\u00edtez  del Castillo S\u00e1nchez", "title": "Legal Department Mang.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Fernando  Mart\u00ednez Morales", "title": "Director of Sales", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Rosario  Perucha P\u00e9rez", "title": "Marketing Mang.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Francisco Javier  Angulo Garc\u00eda", "title": "HR Mang.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Gabriel  Nunez Fernandez", "title": "Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 8, "boardRisk": 4, "compensationRisk": 3, "shareHolderRightsRisk": 5, "overallRisk": 3, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}